Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Purpose Phosphorus magnetic resonance spectroscopy ( 31 P-MRS) affords unique insight into cardiac energetics but has a low intrinsic signal-to-noise ratio (SNR) in humans. Theory predicts an increased 31 P-MRS SNR at 7T, offering exciting possibilities to better investigate cardiac metabolism. We therefore compare the performance of human cardiac 31 P-MRS at 7T to 3T, and measure T 1 s for 31 P metabolites at 7T. Methods Matched 31 P-MRS data were acquired at 3T and 7T, on nine normal volunteers. A novel Look-Locker CSI acquisition and fitting approach was used to measure T 1 s on six normal volunteers. Results T 1 s in the heart at 7T were: phosphocreatine (PCr) 3.05 ± 0.41s, γ-ATP 1.82 ± 0.09s, α-ATP 1.39 ± 0.09s, β-ATP 1.02 ± 0.17s and 2,3-DPG (2,3-diphosphoglycerate) 3.05 ± 0.41s (N = 6). In the field comparison (N = 9), PCr SNR increased 2.8× at 7T relative to 3T, the Cramer-Ráo uncertainty (CRLB) in PCr concentration decreased 2.4×, the mean CRLB in PCr/ATP decreased 2.7× and the PCr/ATP SD decreased 2×. Conclusion Cardiac 31 P-MRS at 7T has higher SNR and the spectra can be quantified more precisely than at 3T. Cardiac 31 P T 1 s are shorter at 7T than at 3T. We predict that 7T will become the field strength of choice for cardiac 31 P-MRS. Magn Reson Med 72:304-315, 2014. © 2013 Wiley Periodicals, Inc. Copyright © 2013 Wiley Periodicals, Inc.

Original publication

DOI

10.1002/mrm.24922

Type

Journal article

Journal

Magnetic Resonance in Medicine

Publication Date

01/01/2014

Volume

72

Pages

304 - 315